Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmacology / Federal assistance in the United States / Healthcare reform in the United States / Presidency of Lyndon B. Johnson / Healthcare Systems Bureau / Orphan drug / Orphan Drug Act / Food and Drug Administration / Health / Medicine / Pharmaceutical sciences


Document Date: 2012-10-04 17:58:42


Open Document

File Size: 200,16 KB

Share Result on Facebook

City

Rockville / /

Company

Services Administration / Covered Entities / Certain Covered Entities Under 340B Program Health Resources / Health Resources / Human Services / /

Country

United States / /

Currency

USD / /

/

Event

FDA Phase / Labor Issues / /

Facility

Parklawn Building / Pharmacy Affairs / /

IndustryTerm

health care services / pharmaceutical manufacturers / outpatient services / drug manufacturer / orphan products / outpatient early intervention services / treatment of rare diseases / local law / internal data systems / manufacturing / treatment of sexually transmitted diseases / manufacturing orphan drugs / orphan drug products / /

MedicalCondition

particular disease / then freestanding cancer / rare diseases / common disease / PROPOSALS standing cancer / certain free-standing cancer / different disease / common diseases / hemophilia / cancer / disease / free-standing cancer / free standing cancer / rare disease / diseases / AIDS / certain free standing cancer / then free-standing cancer / HIV disease / sexually transmitted diseases / tuberculosis / /

Organization

Food and Drug Administration / FDA Center for Drug Evaluation and Research / office of Pharmacy Affairs / Public Health Service / office of Management and Budget / Healthcare Systems Bureau / U.S. Securities and Exchange Commission / Health Resources and Services Administration / Medicare / Congress / Certain Covered Entities Under 340B Program Health Resources and Services Administration / Hawaiian Health Center / national government / Services Administration / An / DEPARTMENT OF HEALTH AND HUMAN SERVICES / office of Orphan Products Development / Center for Biologics Evaluation and Research / /

Person

Jared Blumenfeld / Krista Pedley / Mary Wakefield / Kathleen Sebelius / /

/

Position

Secretary of Health / Regulatory Impact Executive / General / Secretary / Regional Administrator / Region IX / Governor / Regulation General / Director / Executive / Administrator / /

Product

Federal Food / 10.3 Covered outpatient drug / Which / DSK2BSOYB1PROD / /

ProvinceOrState

Maryland / /

Technology

http / /

URL

www.accessdata.fda.gov/scripts / www.regulations.gov / /

SocialTag